Even chatbots get the blues. According to a new study, OpenAI’s artificial intelligence tool ChatGPT shows signs of anxiety when its users share “traumatic narratives”...
Every day, Dora Dantzler-Wright and her colleagues distribute overdose reversal drugs on the streets of Chicago. They hold training sessions on using them and help...
The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant schizophrenia,...
The nation’s largest association of psychologists this month warned federal regulators that A.I. chatbots “masquerading” as therapists, but programmed to reinforce, rather than to challenge,...
Hospital and emergency room patients diagnosed with cannabis use disorder — defined as an inability to stop using cannabis even when the drug is causing...
After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was...
